CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Removal of dead space filterWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Influence of External Dead Space on Volumetric Capnography Derived Parameters in Mechanically Ventilated COVID-19 Patients

The objective is to investigate the efficacy of volumetric capnography to detect changes in dead space, CO2 elimination and shape factor parameters before and after disconnection of external dead space in ventilated COVID-19 patients.

NCT04424082 Coronavirus ARDS, Human Other: Removal of dead space filter
MeSH:Respiratory Distress Syndrome, Adult

Primary Outcomes

Description: VCO2 is expected to increase after removal of the external dead space

Measure: change in carbon dioxide elimination (VCO2) i.e. ml CO2 eliminated/minute

Time: 60 minutes

Secondary Outcomes

Description: Removing the external dead space is expected to decrease alveolar dead space (ml)

Measure: Changes in alveolar dead space (a Vcap derived parameter)

Time: 60 minutes

Description: Removal of external dead space is expected to decrease PaCO2 (kPa).

Measure: Changes in arterial carbon dioxide tension (PaCO2).

Time: 60 minutes


No related HPO nodes (Using clinical trials)